Dataset Open Access
Van Damme, Ellen
<?xml version='1.0' encoding='utf-8'?> <resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd"> <identifier identifierType="DOI">10.5281/zenodo.5838690</identifier> <creators> <creator> <creatorName>Van Damme, Ellen</creatorName> <givenName>Ellen</givenName> <familyName>Van Damme</familyName> <affiliation>Janssen Pharmaceutica NV</affiliation> </creator> </creators> <titles> <title>Virtual screening of 2629 Janssen compounds against SARS-CoV-2 RdRP</title> </titles> <publisher>Zenodo</publisher> <publicationYear>2022</publicationYear> <dates> <date dateType="Issued">2022-01-11</date> </dates> <resourceType resourceTypeGeneral="Dataset"/> <alternateIdentifiers> <alternateIdentifier alternateIdentifierType="url">https://zenodo.org/record/5838690</alternateIdentifier> </alternateIdentifiers> <relatedIdentifiers> <relatedIdentifier relatedIdentifierType="DOI" relationType="IsVersionOf">10.5281/zenodo.5838689</relatedIdentifier> <relatedIdentifier relatedIdentifierType="URL" relationType="IsPartOf">https://zenodo.org/communities/covid-19</relatedIdentifier> </relatedIdentifiers> <rightsList> <rights rightsURI="https://creativecommons.org/licenses/by/4.0/legalcode">Creative Commons Attribution 4.0 International</rights> <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights> </rightsList> <descriptions> <description descriptionType="Abstract"><p>This short report describes the most relevant results of virtually screening the Janssen Pharmaceutica compound collection for potential activity against SARS-CoV-2 RdRP and confirmation of potential hits in a VeroE6 cell-based anti-SARS-CoV-2 assay.</p></description> </descriptions> </resource>
All versions | This version | |
---|---|---|
Views | 100 | 100 |
Downloads | 2 | 2 |
Data volume | 294.1 kB | 294.1 kB |
Unique views | 97 | 97 |
Unique downloads | 2 | 2 |